Harrow HROW
NASDAQ HROW
$37.80 -0.05 (-0.13%)
As of: Sep 9, 2026 · 1:48 PM EDT

Harrow (HROW) Other Non-Current Assets (2012 - 2022)

Harrow (HROW) posted Other Non-Current Assets of $2.0 million for Q4 2022, up 875.0% on a QoQ basis from $200000.0 in Q3 2021.

Analysis

Harrow (HROW) Other Non-Current Assets (2012 - 2022) Analysis & Trends

Harrow has reported Other Non-Current Assets for 7 years, with the latest figure at $2.0 million in Q4 2022.

  • On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $2.0 million in Q4 2022; TTM through Dec 2022 was $2.0 million, a N/A change from a year earlier, with the FY2022 full-year figure at $2.0 million, changed N/A from the prior year.
  • Other Non-Current Assets was $2.0 million for Q4 2022 at Harrow, up from $200000.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $2.0 million in Q4 2022, with the low at $200000.0 in Q1 2018.
  • Average Other Non-Current Assets over 5 years is $309375.0, with a median of $200000.0 recorded in 2018.
  • The largest YoY upside for Other Non-Current Assets was 0.0% in 2018 against a maximum downside of 68.3% in 2018.
  • Over 5 years, Other Non-Current Assets stood at $200000.0 in 2018, then changed by 0.0% to $200000.0 in 2019, then changed by 0.0% to $200000.0 in 2020, then changed by 0.0% to $200000.0 in 2021, then jumped by 875.0% to $2.0 million in 2022.
  • The last three Other Non-Current Assets figures came in at $2.0 million (Q4 2022), $200000.0 (Q3 2021), and $200000.0 (Q2 2021), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 645.47 Bn 624.71 Bn 17.26 Bn 14.27 Bn
2 AbbVie 439.99 Bn 433.42 Bn 12.70 Bn 10.73 Bn
3 Merck 365.45 Bn 358.31 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 266.57 Bn 258.88 Bn 11.24 Bn 5.93 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn 9.94 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn 5.50 Bn
7 Revolution Medicines 44.23 Bn 44.23 Bn - 42.45 Mn
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn 86.76 Mn
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn 239.50 Mn
10 Harrow 1.42 Bn 1.33 Bn 50.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.95 Mn
Sep 30, 2021 200,000.00
Jun 30, 2021 200,000.00
Mar 31, 2021 200,000.00
Dec 31, 2020 200,000.00
Sep 30, 2020 200,000.00
Jun 30, 2020 200,000.00
Mar 31, 2020 200,000.00
Dec 31, 2019 200,000.00
Sep 30, 2019 200,000.00
Jun 30, 2019 200,000.00
Mar 31, 2019 200,000.00
Dec 31, 2018 200,000.00
Sep 30, 2018 200,000.00
Jun 30, 2018 200,000.00
Mar 31, 2018 200,000.00
Dec 31, 2017 200,000.00
Sep 30, 2017 631,000.00
Jun 30, 2017 631,000.00
Dec 31, 2012 596,281.00